The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

Pneumonia, frequently intertwined with cardiovascular disease, escalates the risk of heart complications like heart attacks ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

A history of HDP is linked to increased risks of myocardial infarction, whether that’s with obstructive ... conditions that ...

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

WASHINGTON — Colchicine does not protect against major cardiovascular adverse events after an acute myocardial infarction, according to a multinational ... In LODOCO2, which randomized 5522 patients ...

Clinicians treating patients with kidney disease must be aware of dental considerations to avoid potentially lethal consequences.

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...

Kidney failure deaths in Maharashtra have doubled from 2018 to 2023, with those aged 45 and above being most at risk. Experts ...